We have located links that may give you full text access.
JOURNAL ARTICLE
META-ANALYSIS
Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis.
Pancreas 2009 March
OBJECTIVES: To determine the prophylactic effect of antibiotics on post-endoscopic retrograde cholangiopancreatography (ERCP) cholangitis or sepsis reduction in randomized controlled trials.
METHODS: Databases including MEDLINE, EMBASE, Cochrane Library, and Science Citation Index updated to June 2007 were searched. Main outcome measure was post-ERCP cholangitis or sepsis.
RESULTS: Seven trials were identified, and a total of 1389 patients were included; post-ERCP cholangitis occurred in 5.8% of controls (41/705) versus 3.4% of treated patients (23/684), without statistical significance (relative risk [RR], 0.58; 95% confidence interval [CI], 0.22-1.55). Subsequent sensitivity analysis on trials mainly targeted at patients with suspicious biliary obstruction showed that the incidences of post-ERCP cholangitis were 2.8% (12/425) and 5.4% (24/441) in the antibiotics and control groups, respectively, and this sensitivity analysis did not support antibiotics' preventive effect (RR, 0.33; 95% CI, 0.03-3.32). Another sensitivity analysis exclusively including trials with intravenous route of antibiotics administration also failed to confirm the prophylactic effect of antibiotics (RR, 0.53; 95% CI, 0.18-1.60).
CONCLUSIONS: Antibiotics cannot significantly prevent ERCP-induced cholangitis in unselected patients and should not be routinely recommended. Yet, more trials including patients with predicted incomplete biliary drainage are still required to prove the effectiveness of prophylactic antibiotics in this setting.
METHODS: Databases including MEDLINE, EMBASE, Cochrane Library, and Science Citation Index updated to June 2007 were searched. Main outcome measure was post-ERCP cholangitis or sepsis.
RESULTS: Seven trials were identified, and a total of 1389 patients were included; post-ERCP cholangitis occurred in 5.8% of controls (41/705) versus 3.4% of treated patients (23/684), without statistical significance (relative risk [RR], 0.58; 95% confidence interval [CI], 0.22-1.55). Subsequent sensitivity analysis on trials mainly targeted at patients with suspicious biliary obstruction showed that the incidences of post-ERCP cholangitis were 2.8% (12/425) and 5.4% (24/441) in the antibiotics and control groups, respectively, and this sensitivity analysis did not support antibiotics' preventive effect (RR, 0.33; 95% CI, 0.03-3.32). Another sensitivity analysis exclusively including trials with intravenous route of antibiotics administration also failed to confirm the prophylactic effect of antibiotics (RR, 0.53; 95% CI, 0.18-1.60).
CONCLUSIONS: Antibiotics cannot significantly prevent ERCP-induced cholangitis in unselected patients and should not be routinely recommended. Yet, more trials including patients with predicted incomplete biliary drainage are still required to prove the effectiveness of prophylactic antibiotics in this setting.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app